Truist analyst Tobey Sommer raised the firm’s price target on Exponent to $120 from $100 and keeps a Buy rating on the shares. The analyst cites the company’s strong Q2 results, upside Q3 guidance, and rising utilization to 75% from 69%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO: